Desarrollo de nuevas moléculas hepatoprotectoras y pro-regenerativas basadas en el factor de crecimiento de fibroblastos 15/19 (FGF15/19) y la anfirregulina (AR)
PI13/00385
•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+I Orientada a los Retos de la Sociedad
Subprograma Salud, cambio demográfico y bienestar
Convocatoria Proyectos de investigación en salud (AE en Salud)
Año convocatoria 2013
Unidad de gestión Instituto de Salud Carlos III (ISCIII)
Centro beneficiario FUNDACIÓN PARA LA INVESTIGACIÓN MÉDICA APLICADA (FIMA)
Centro realización FUNDACION PARA LA INVESTIGACION MEDICA APLICADA
Identificador persistente http://dx.doi.org/10.13039/501100003329
Publicaciones
Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)
Encontrada(s) 1 página(s)
Splicing events in the control of genome integrity: role of SLU7 and truncated SRSF3 proteins
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
- Jiménez, Maddalen
- Urtasun Alonso, Raquel
- Elizalde, María
- Azkona, María
- Latasa, Maria Ujue
- Uriarte, Iker
- Arechederra, María
- Alignani, Diego
- Bárcena-Varela, Marina
- Álvarez-Sola, Gloria
- Colyn, Leticia
- Santamaría, Eva
- Sangro, Bruno
- Rodriguez-Ortigosa, Carlos
- Fernández-Barrena, Maite G.
- Ávila, Matías A.
- Berasain, Carmen
Genome instability is related to disease development and carcinogenesis. DNA lesions are caused by genotoxic compounds but also by the dysregulation of fundamental processes like transcription, DNA replication and mitosis. Recent evidence indicates that impaired expression of RNA-binding proteins results in mitotic aberrations and the formation of transcription-associated RNA-DNA hybrids (R-loops), events strongly associated with DNA injury. We identify the splicing regulator SLU7 as a key mediator of genome stability. SLU7 knockdown results in R-loops formation, DNA damage, cell-cycle arrest and severe mitotic derangements with loss of sister chromatid cohesion (SCC). We define a molecular pathway through which SLU7 keeps in check the generation of truncated forms of the splicing factor SRSF3 (SRp20) (SRSF3-TR). Behaving as dominant negative, or by gain-of-function, SRSF3-TR impair the correct splicing and expression of the splicing regulator SRSF1 (ASF/SF2) and the crucial SCC protein sororin. This unique function of SLU7 was found in cancer cells of different tissue origin and also in the normal mouse liver, demonstrating a conserved and fundamental role of SLU7 in the preservation of genome integrity. Therefore, the dowregulation of SLU7 and the alterations of this pathway that we observe in the cirrhotic liver could be involved in the process of hepatocarcinogenesis., CIBERehd; Instituto de Salud Carlos III (ISCIII) [PI13/00359, PI13/00385]; MINECO/AEI/FEDER,UE [SAF2016-75972-R]; HEPACARE Project from Fundación La Caixa; Ministerio de Educación FPI Fellowship, Cultura y Deporte; ADA-UNAV and CIMA Fellowships; AECC Post-doctoral Fellowship; Fundación Eugenio Rodríguez Pascual; Fundación Echebano; Fundación Mario Losantos; Fundación M Torres and Mrs Eduardo Ávila and Sergio Durá contribution. Funding for open access charge: MINECO/AEI/FEDER,UE [SAF2016-75972-R].